Clinical trials · North Carolina
Insomnia clinical trials in North Carolina
We’re tracking 9 recruiting insomnia studies with a site in North Carolina — including Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies in North Carolina
- NCT05663034Recruiting
Compare CBT-I vs MBTI for sleep and trauma symptoms after TBI
This study compares two types of talk-based therapy to help veterans with long-lasting insomnia after a traumatic brain injury (TBI), and also looks at related post-trauma stress symptoms. It may help you improve sleep and reduce how much these symptoms affect daily life.
Fort Bragg, North CarolinaAges 18 years+ - NCT06498128Recruiting
Pregnancy safety registry for insomnia drug QUVIVIQ
This registry follows pregnant women with insomnia who used or did not use the sleep medication QUVIVIQ. It aims to track pregnancy and baby outcomes to understand safety.
Durham, North CarolinaAges 15–50 - NCT07136415RecruitingPhase 4
Comparing digital therapy, trazodone, and daridorexant for menopause insomnia
This trial tests three different treatments for insomnia that started or got worse during the menopausal transition. One is a digital therapy app, and the others are two different medications. The goal is to see which works best for women aged 40–62 who are in the early stages of menopause.
Winston-Salem, North CarolinaAges 40–62 - NCT07216261Recruiting
The SWELL study: CBT for insomnia in older veterans
This trial tests whether providing cognitive behavioral therapy for insomnia (CBTI) can help older veterans in VA clinics. CBTI is a non-medication treatment that addresses the thoughts and behaviors that keep you awake.
Durham, North CarolinaAges 60 years+ - NCT04278404Recruiting
Drug safety study for children already on certain medicines
This study measures how certain medicines move through the body and checks their safety in children. It may help doctors better understand dosing and side effects in kids who are already receiving these treatments, or in some kids who recently tested positive for COVID-19.
Chapel Hill, North CarolinaAges birth–20 years - NCT06262594RecruitingPhase 3
Testing a sleep medicine for epilepsy-related insomnia
This study tests a new sleep medicine called lemborexant for people with epilepsy whose seizures happen during sleep and who also have trouble sleeping. The goal is to see if the medicine can help you sleep better without making your seizures worse.
Durham, North CarolinaAges 18 years+ - NCT06559306RecruitingPhase 3
Seltorexant for depression with insomnia symptoms
This trial tests if adding seltorexant to your current antidepressant can improve depression and sleep problems. It is for people with major depressive disorder who still have symptoms, especially insomnia, despite trying at least one antidepressant.
Hickory, North CarolinaAges 18–74 - NCT07196332Recruiting
Recovering sleep after a car accident
This study tests a remote therapy program to help people who have been in a car accident and are at risk for PTSD. The goal is to see if improving sleep soon after a trauma can prevent PTSD symptoms.
Chapel Hill, North CarolinaAges 18–65 - NCT06378554Enrolling by invitation
Cereset study for stress and performance in nurses
This study tests whether a new brain-calming technique called Cereset can help healthcare workers on the Orthopedic Trauma Unit feel less stressed and perform better. You would sit in a chair and listen to gentle sounds that help your brain relax.
Winston-Salem, North CarolinaAges 18–100
Where these studies are running in North Carolina
Institutions with a site for the recruiting insomnia studies listed above.
- University of North Carolina at Chapel Hill · 2 studies
- Atrium Health Wake Forest Baptist Medical Center (Wake Forest Baptist)
- Duke University
- Duke University Health System
- Durham VA Medical Center
- IMA Clinical Research PC 3
- IQVIA US Office
- Wake Forest University Health Sciences
What taking part in a insomnia study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Insomnia trials in other states
Common questions
- Are there insomnia clinical trials in North Carolina?
- Yes. We're currently tracking 9 recruiting insomnia studies with a site in North Carolina, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a insomnia study in North Carolina?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in North Carolina to take part?
- Not necessarily. These studies have a site in North Carolina, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a insomnia trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New insomnia studies open in North Carolina regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.